Ticker League

Operating Income for Insulet (PODD)

Latest filings through · Reported

Metric

TTM

$507.20M

YoY change

+53.4%

5Y CAGR

+55.9%

Peak year (2025)

$473.80M

Operating Income history chart for Insulet (PODD) from 2002 to 2025

Latest: $473.80M

Operating Income growth chart for Insulet (PODD) from 2002 to 2025

Latest: +53.4%

Operating Income history table for Insulet (PODD) from 2002 to 2025

  • 2025$473.80M+53.4%
  • 2024$308.90M+40.4%
  • 2023$220.00M+485.1%
  • 2022$37.60M-70.2%
  • 2021$126.00M+144.7%
  • 2020$51.50M+3.0%
  • 2019$50.00M+82.5%
  • 2018$27.40M-470.3%
  • 2017−$7.40M-30.9%
  • 2016−$10.70M-78.0%
  • 2015−$48.74M+449.2%
  • 2014−$8.87M-69.5%
  • 2013−$29.14M-19.0%
  • 2012−$35.97M-15.3%
  • 2011−$42.47M+9.9%
  • 2010−$38.63M-34.9%
  • 2009−$59.36M-33.6%
  • 2008−$89.34M+65.9%
  • 2007−$53.84M+55.4%
  • 2006−$34.65M+61.1%
  • 2005−$21.50M+51.9%
  • 2004−$14.15M+17.8%
  • 2003−$12.01M-5.2%
  • 2002−$12.67M—

Operating Income values are taken from Insulet's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Income at Insulet (PODD)

According to Insulet's latest reported financial statements, the company's current operating income (TTM) is $507.20M. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

Insulet (PODD) most recent annual operating income stands at $473.80M (2025) – surged 53.4% year-over-year.

Looking at the 2020–2025 (5 years) stretch, Insulet operating income compounded at +55.9% per year, sustaining 3 straight years of year-over-year growth.

2025 marks the peak operating income at $473.80M, with the historical low of −$89.34M recorded in 2008.

Insulet Operating Income by Year

Insulet Operating Income 2025: $473.80M

Insulet posted operating income of $473.80M in 2025, surged 53.4% from 2024. This figure represents the highest annual value in the available history.

Insulet Operating Income 2024: $308.90M

In 2024, Insulet reported operating income of $308.90M, surged 40.4% from 2023.

Insulet Operating Income 2023: $220.00M

Insulet operating income in 2023 was $220.00M, surged 485.1% from 2022.

Insulet Operating Income 2022: $37.60M

2022's operating income for Insulet came in at $37.60M, plunged 70.2% below 2021.

Insulet Operating Income 2021: $126.00M

Insulet operating income in 2021 was $126.00M.

See more financial history for Insulet (PODD).

Sector peers by Operating Income

Healthcare peers of Insulet (PODD), ranked by their latest operating income

Frequently asked questions

Insulet (PODD) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Capital Return